Hot flash drug may unlock heart health secrets in midlife women
NCT ID NCT07077395
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a medication called elinzanetant, which is used for hot flashes, can also improve blood vessel health in women aged 40-65. Participants must have moderate to severe hot flashes and at least two heart risk factors like obesity or high blood pressure. The goal is to see if treating hot flashes can lower the risk of heart disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENOPAUSE-RELATED HOT FLASHES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.